首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.
【2h】

Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.

机译:通过针对猪血管性血友病因子的鼠类单克隆抗体预防阻塞性冠状动脉血栓形成。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A murine monoclonal antibody (mAb) against porcine von Willebrand factor (vWF) induced an antithrombotic state in normal pigs. Thrombosis was induced by a standard procedure of stenosis and mechanical injury of the artery. The mAb was an IgG1 kappa that inhibited vWF-induced platelet aggregation at a titer of 1:6250 and bound to immobilized vWF at a maximal dilution of 1:512,000. The antibody did not affect two other vWF functions, platelet adhesion and binding of coagulant factor VIII (factor VIII:C). The antithrombotic state was characterized by a prolonged bleeding time and lack of plasma vWF activity, but with near-normal levels of factor VIII:C and von Willebrand antigen. The circulating Ag.mAb complex demonstrated a multimeric distribution comparable to that of native plasma vWF. Three groups of pigs were studied: group A consisted of nine untreated animals, eight of which developed occlusive coronary thrombosis; group B, four treated animals with a long bleeding time, none of which developed occlusive thrombosis; and group C, two animals with preexisting thrombosis treated with mAb, in which stable blood flow was reestablished. Morphologically, the group B animals showed adherent platelets covering the injured intima but no thrombosis. This mAb is an antithrombotic agent that prevents platelet thrombosis without affecting intrinsic platelet function.
机译:针对猪血管性假血友病因子(vWF)的鼠单克隆抗体(mAb)在正常猪中诱导了抗血栓形成状态。通过狭窄和动脉的机械损伤的标准程序诱发血栓形成。 mAb是一种IgG1 kappa,它以1:6250的滴度抑制vWF诱导的血小板凝集,并以1:512,000的最大稀释度与固定的vWF结合。该抗体不影响其他两个vWF功能,即血小板粘附和凝血因子VIII(因子VIII:C)的结合。抗血栓形成状态的特征是出血时间延长和血浆vWF活性不足,但凝血因子VIII:C和von Willebrand抗原水平接近正常水平。循环的Ag.mAb复合物表现出与天然血浆vWF相当的多聚体分布。研究了三组猪:A组由9只未经治疗的动物组成,其中8只出现了闭塞性冠状动脉血栓形成; A组由9只未治疗的动物组成。 B组,四只治疗动物,出血时间长,均未发生闭塞性血栓形成。和C组,两只已经患有血栓形成的动物,用mAb治疗后,血流恢复稳定。形态上,B组动物显示出粘附的血小板覆盖受伤的内膜,但没有血栓形成。该mAb是抗血栓药,可防止血小板血栓形成,而不会影响固有的血小板功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号